8-K
Current Report
Avalo Therapeutics, Inc. Filed Acc 0001104659-26-123079
Material agreement · Agreement ended
- Item 1.01 Entry into a material definitive agreement
- Item 1.02 Termination of a material definitive agreement
From the SEC's structured data for this filing
Loading tm2628583d1_8k.htm…